Industry News
Abselion establishes US subsidiary in Cambridge, Massachusetts
Supports closer engagement with scientists in North America, to meet growing international adoption of its Amperia protein quantification platform
Supports closer engagement with scientists in North America, to meet growing international adoption of its Amperia protein quantification platform
Ready-to-use solution, developed in collaboration with GenScript, offers rapid and reliable quantification of His-tagged proteins
Ready-to-use solution for Amperia benchtop platform supports rapid, reliable quantification across a range of serotypes
New kit enables rapid, accurate titer measurement across broad range of IgG subclasses and species on Amperia platform
Series A financing highlights the potential impact of Abselion’s technology for life science research and bioprocess development